| Name | 1-[(5-methoxy-2-thiophen-2-ylquinazolin-4-yl)amino]-3-methylpyrrole-2,5-dione |
|---|---|
| Synonyms |
a4715
spc-839 |
| Description | SPC 839 (compound 10) is an orally active inhibitor of AP-1 and NF-kB mediated transcriptional activation with IC50 of 0.008 μM[1]. |
|---|---|
| Related Catalog | |
| In Vivo | SPC 839 (compound 10) (30 mg/kg, p.o., 21 days) 在佐剂诱导的关节炎大鼠模型中显示显著活性,使未注射足部肿胀减少 65%[1]。 |
| References |
| Density | 1.475 |
|---|---|
| Molecular Formula | C18H14N4O3S |
| Molecular Weight | 366.39 |
| Exact Mass | 366.07900 |
| PSA | 115.89000 |
| LogP | 2.36870 |
| Precursor 3 | |
|---|---|
| DownStream 0 | |